Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-589-1 | CAS number: 6300-50-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute toxicity of the substance has been determined in adequate studies in the rat following oral and dermal administration. No studies are available for inhalation.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Adult, young, albino, Wistar ITA177 SPF strain are used. Rats have been bred and kept in rooms with spf conditioning. The temperature is 24+-1 ° C and the humidity is 65+-5%.
The lighting is artificial, following periods of light and darkness of 12 h. - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- All rats remain fasting approximately 18 hours before and 4 hours after administration. The rest of the time they received UAR D-04 sterilized feed and demineralised water "as libitum".
Rats are administered orally by means of a esophageal probe, the product suspended or dissolved in a solution of 1% tween 80 and 2% carboxymethylcellulose in distilled water.
Liquid products, if possible, are given undiluted.
Dose levels are chosen in progression and the products are administered according to the individual body weights of the rats (mg / kg or ml / kg).
The maximum dose used is 16 mg / kg or 16 ml / kg. The volume administered when using vehicle is 10 ml / kg. At high doses, the volume can be increased to a maximum of 40 ml / kg to facilitate the suspension of the product.
The control group receives only vehicle at the maximum volume administered. - Doses:
- 4 mg/kg bw, 8 mg/kg bw, 11.3 mg/kg bw, 16 mg/kg bw
- No. of animals per sex per dose:
- 10 animals per dose
- Control animals:
- yes
- Details on study design:
- Body weights are recorded for each rat immediately prior to administration, and thereafter at weekly intervals.
Animals are often observed on the day of the administration, and then at least once a day for 14 days.
Symptoms of reaction to treatment are recorded in terms of approximate time of onset, duration and intensity.
The circumstances of each death are recorded and the autopsy performed, which includes the opening of the abdominal and thoracic cavities, as well as the cranial cavity if the observations indicate neurotoxic activity. The organs are examined microscopically and the observed alterations are noted.
All surviving animals at the end of the observation period are sacrificed and undergo the same autopathic examination.
The 14-day observation period will be extended if the general condition of the animals is not considered satisfactory or if delayed toxicity is noted.
The LD50 value is calculated from the mortality data found using the method of Litchfield and Wilcoxon. - Preliminary study:
- The preliminary study has an experimental design similar to the one of the study, but using a smaller number of animals (2 males and 2 females per group).
If the LD50 is found to be equal to or greater than 16 g / kg (16 ml / kg in the case of liquid) during the preliminary study, the exact value of LD50 is not determined.
If LD50 is found to be only slightly lower than 16 g / kg (16 ml / kg in the case of liquids), its value is determined even if four dose levels are not administered. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 14.8 mL/kg bw
- Based on:
- act. ingr.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 516 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- The day after the adminsitration the observed mortality was:
Dose 16ml/kg: 60% (4 males, 2 females)
Dose 11,3 ml/kg: 20% (1 male, 1 female)
Dose 8 ml/kg: 10% (1 male)
Dose 4 ml/kg: 0% - Clinical signs:
- other: Not observed
- Gross pathology:
- Not observed
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The substance has been found to have a LD50 of 14.8 (11.3-19.3) ml / kg when administered orally.
Rats died on the first day after administration without showing external signs of toxicity. There were no macroscopic alterations at autopsies.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 516 mg/kg bw
- Quality of whole database:
- The study is a not GLP compliant one, but the Klimisch score is 1
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- There isn’t any test available for acute inhalation toxicity. According to the column 2 of annex VIII, the choice for the second route will depend on the nature of the substance and the likely route of human exposure. Information on dermal toxicity is provided, as considered more relevant for this substance.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- For the purpose of the study the test item was ground to a fine powder using a mortar and pestle and weighed out according to each animal’s individual body weight. The test item was moistened with distilled water prior to application.
The absorption of the test item was not determined. - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 3.3.1 Animal Information
Five male and five female Wistar (RccHanTM:WIST) strain rats were supplied by Envigo RMS (UK) Limited, Oxon, UK. On receipt the animals were randomly allocated to cages. The females were nulliparous and non-pregnant. After an acclimatization period of at least 5 days the animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and a number written on a cage card. At the start of the study the animals weighed at least 200 g, and were 8 to 12 weeks of age. The weight variation did not exceed ±20% of the mean weight for each sex.
3.3.2 Animal Care and Husbandry
The animals were housed in suspended solid floor polypropylene cages furnished with woodflakes. The initial two animals were housed individually throughout the study. The further group of eight animals (four male and four female) were housed individually during the 24-Hour exposure period and in groups of four, by sex, for the remainder of the study. Free access to mains drinking water and food (2014C Teklad Global Rodent diet supplied by Envigo RMS (UK) Limited, Oxon, UK) was allowed throughout the study. The diet, drinking water and bedding were routinely analyzed and were considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
The temperature and relative humidity were set to achieve limits of 19 to 25ºC and 30 to 70% respectively. The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness.
The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study. - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- Applied on an area of shorn skin (approximately 10% of the total body surface area).
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- On the day before treatment the back and flanks of each animal were clipped free of hair.
In the absence of data suggesting the test item was toxic, one male and one female rat were initially treated with the test item at a dose level of 2000 mg/kg.
The appropriate amount of test item, moistened with distilled water, was applied as evenly as possible to an area of shorn skin (approximately 10% of the total body surface area). A piece of surgical gauze was placed over the treatment area and semi-occluded with a piece of self-adhesive bandage. The animals were caged individually throughout the study. Shortly after dosing the dressings were examined to ensure that they were securely in place.
After the 24-Hour contact period the bandage was carefully removed and the treated skin and surrounding hair wiped with cotton wool moistened with distilled water to remove any residual test item.
As no mortalities were noted a further group of animals (four males and four females) was similarly treated with the test item at a dose level of 2000 mg/kg body weight to give a total of five males and five females. The animals were caged individually for the 24-Hour exposure period. After the 24-Hour contact period the bandages were carefully removed and the treated skin and surrounding hair wiped with cotton wool moistened with distilled water to remove any residual test item. These animals were returned to group housing for the remainder of the test period.
The animals were observed for deaths or overt signs of toxicity 30 minutes, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days.
After removal of the dressings and subsequently once daily for 14 days, the test sites were examined for evidence of primary irritation and scored according to the following scale:
EVALUATION OF SKIN REACTIONS:
Erythema and Eschar Formation
No erythema, 0
Very slight erythema (barely perceptible), 1
Well-defined erythema, 2
Moderate to severe erythema, 3
Severe erythema (beef redness) to slight eschar formation (injuries in depth), 4
Edema Formation
No edema, 0
Very slight edema (barely perceptible), 1
Slight edema (edges of area well-defined by definite raising), 2
Moderate edema (raised approximately 1 millimeter), 3
Severe edema (raised more than 1 millimeter and extending beyond the area of exposure),4
Any other skin reactions, if present were also recorded.
Individual body weights were recorded prior to application of the test item on Day 0 and on Days 7 and 14.
At the end of the study the animals were killed by cervical dislocation. All animals were subjected to gross necropsy. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- no indication of skin irritation up to the relevant limit dose level
- Mortality:
- There were no deaths.
- Clinical signs:
- other: There were no signs of systemic toxicity.
- Gross pathology:
- No abnormalities were noted at necropsy
- Other findings:
- Dermal Irritation. No signs of dermal irritation were noted at the test sites of the two initial treated animals. Very slight erythema was noted at the test sites of the further group of eight animals. Other signs of dermal irritation noted were small superficial scattered scabs, glossy skin and scab lifting to reveal glossy skin
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute dermal median lethal dose (LD50) of the test item in the Wistar strain rat was found to be greater than 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is a GLP compliant and has Klimisch score 1
Additional information
Justification for classification or non-classification
Acute oral toxicity
Based on the results of acute oral toxicity testing, the substance has not to be classified for this hazard class following the criteria of the EU Regulation 1272/2008 (CLP Regulation). The criteria in CLP Regulation stablishes the limit for classification as Acute Tox Oral Category 4 in 2000 mg/kg, and the value obtained is >2000 mg/kg bw.
Acute inhalation toxicity
There isn’t any test available for acute inhalation toxicity. According to the column 2 of annex VIII, the choice for the second route will depend on the nature of the substance and the likely route of human exposure. Information on dermal toxicity is provided, as considered more relevant for this substance.
Acute dermal toxicity
Based on the results of acute dermal toxicity testing, the substance has not to be classified for this hazard class following the criteria of the EU Regulation 1272/2008 (CLP Regulation).The criteria in CLP Regulation stablishes the limit for classification as Acute Tox Dermal Category 4 in 2000 mg/kg, and this is the value obtained in the limit test conducted with the substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.